Oaks, PA, United States of America

Robert D Groneberg

This inventor holds 1 USPTO granted patent. Top assignee: Scripps Research Institute. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert D Groneberg. Retrieved from https://idiyas.com/inventor/robert-d-groneberg-idxfyaz3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 80(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Robert D. Groneberg

Introduction

Robert D. Groneberg is a notable inventor based in Oaks, Pennsylvania. He has made significant contributions to the field of chemistry, particularly in the development of saccharide intermediates. His work has implications for the creation of chimeric antibiotics, showcasing his innovative approach to solving complex scientific problems.

Latest Patents

Groneberg holds a patent for "Saccharide intermediates in the formation of the calicheamicin." This patent details intermediates useful in preparing calicheamicin and esperamicin oligosaccharides. It specifically focuses on the sulfur- and O-substituted hydroxylamine-containing B ring of both oligosaccharides. The patent also outlines methods for making and using these intermediates, including the preparation of chimeric antibiotics.

Career Highlights

Groneberg is affiliated with the Scripps Research Institute, where he has been able to apply his expertise in chemistry. His work at this prestigious institution has allowed him to collaborate with other leading scientists in the field.

Collaborations

Some of his notable coworkers include Wilhelm Stahl and Erwin Paul Schreiner. Their collaborative efforts have contributed to advancements in the understanding and application of oligosaccharides in antibiotic development.

Conclusion

Robert D. Groneberg's innovative work in the field of chemistry, particularly in the development of saccharide intermediates, has the potential to impact antibiotic research significantly. His contributions reflect the importance of collaboration and innovation in scientific advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…